Published

Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Neuroscience Applied
Date: 2026-01-01
Source: OpenAlex
DOI: 10.1016/j.nsa.2025.106390
PubMed: Unavailable

Authors

L. Puhl L. Kunz M. Berger G. Gründer L. Mertens M. Spangemacher

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Chronic Pain Treatment-Resistant Depression Toxicity Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression2026-01-01

Related papers

Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30 From trial to clinic: psilocybin's efficacy in routine treatment-resistant depression.The Lancet regional health. Europe · 2026-08-01 Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic frameworkFrontiers in Psychiatry · 2026-08-12 An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10